The influence of an IL-4 variable number tandem repeat (VNTR) polymorphism on breast cancer susceptibility

References

• Bhikoo R, Srinivasa S, Yu TC, Moss D, Hill AG. Systematic review of breast cancer biology in developing countries (part 2): asian subcontinent and South East Asia. Cancers (Basel). 2011;3(2):2382–2401. doi:10.3390/cancers302238224212815
   PubMedGoogle Scholar
• McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breastcancer-epidemiology, risk factors, and genetics. BMJ. 2000;321(7261):624–628. doi:10.1136/bmj.321.7261.62410977847
   PubMed Web of Science ®Google Scholar
• Tang J, Zhou Q, Zhao F, et al. Association of glutathione S-transferase T1, M1 and P1 polymorphisms in the breast cancer risk: a meta-analysis in Asian population. Int J Clin Exp. 2015;8(8):12430–12447.
   PubMed Web of Science ®Google Scholar
• Youlden DR, Cramb SM, Yip CH, Baade PD. Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med. 2014;11(2):101–115. doi:10.7497/j.issn.2095-3941.2014.02.00525009752
   PubMedGoogle Scholar
• [Internet] Ministry of Health, Jordan Cancer Registry. Cancer Incidence in Jordan; 2012, Available from: http://www.moh.gov.jo/. Accessed 809, 2019.
   Google Scholar
• Verma R, Bowen RL, Slater SE, Mihaimeed F, Jones JL. Pathological and epidemiological factors associated with advanced stage at diagnosis of breast cancer. Br Med Bull. 2012;103(1):129–145.22864058
   PubMed Web of Science ®Google Scholar
• Angahar LT. An overview of breast cancer epidemiology, risk factors, pathophysiology, and cancer risks reduction. MOJ Biol Med. 2017;19(4):1–5.
   Google Scholar
• Zhang B, Beeghly-Fadiel A, Long J, Zheng W. Genetic variants associated with breast cancer risk: comprehensive field synopsis, meta-analysis, and epidemiologic evidence. Lancet Oncol. 2011;12(5):477–488.21514219
   PubMed Web of Science ®Google Scholar
• Han MR, Zheng W, Cai Q, et al. Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians. Carcinogenesis. 2017;38(5):511–518.28419251
   PubMed Web of Science ®Google Scholar
• Leclerc M, Neuhausen SL, Schayek H, Laitman Y, Antonis AC, Friedman E. Are VNTRs co-localizing with breast cancer-associated SNPs? Breast Cancer Res Treat. 2017;168(1):277–281. doi:10.1007/s10549-017-4588-729168065
   PubMed Web of Science ®Google Scholar
• Vasudevan R, Norhasniza MN, Patimah I. Association of variable number of tandem repeats polymorphism in the IL-4 gene with end-stage renal disease in Malaysian patients. Genet Mol Res. 2011;10(2):943–947. doi:10.4238/vol10-2gmr106621644211
   PubMed Web of Science ®Google Scholar
• Nagai S, Toi M. Interleukin-4 and breast cancer. Breast Cancer. 2000;7(3):181–186.11029795
   PubMedGoogle Scholar
• Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999;17:701–738. doi:10.1146/annurev.immunol.17.1.70110358772
   PubMed Web of Science ®Google Scholar
• Gyan BA, Goka B, Cvetkovic JT, et al. Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children. Clin Exp Immunol. 2004;138:145–150. doi:10.1111/j.1365-2249.2004.02590.x15373917
   PubMed Web of Science ®Google Scholar
• Mout R, Willemze R, Landegent JE. Repeat polymorphisms in the interleukin-4 gene (IL4). Nucleic Acids Res. 1991;19(13):3763. doi:10.1093/nar/19.13.3763
   Web of Science ®Google Scholar
• Hosseini-Farahabadi S, Tavakkol-Afshari J, Rafatpanah H, Farid Hosseini R, Khaje Daluei M. Association between the polymorphisms of IL-4 gene promoter (−590C>T), IL-13 coding region (R130Q) and IL-16 gene promoter (−295T>C) and allergic asthma. Iran J Allergy Asthma Immunol. 2007;6(1):9–14. doi: 06.01/ijaai.91417303923
   PubMed Web of Science ®Google Scholar
• Isidoro-García M, Dávila I, Laffond E, Moreno E, Lorente F, González-Sarmiento R. Interleukin-4 (IL4) and interleukin-4 receptor (IL4RA) polymorphisms in asthma: a case control study. Clin Mol Allergy. 2005;29:3–15.
   Google Scholar
• Kok Y, Ong H, Say Y. Interleukin-1 receptor antagonist and interleukin-4 genes variable number tandem repeats are associated with adiposity in Malaysian subjects. J Obes. 2017;1–8. doi:10.1155/2017/4104137
   Web of Science ®Google Scholar
• Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet. 1993;91(4):403–404. doi:10.1007/BF002173688500797
   PubMed Web of Science ®Google Scholar
• Salimi S, Khorasani M, Yaghmaei M, Mokhtari M, Moossavi M. Possible association of IL-4 VNTR polymorphism with susceptibility to preeclampsia. Biomed Res Int. 2014;1–5.
   Web of Science ®Google Scholar
• Salimi S, Khorasani M, Namazi L, Moossavi M, Naghavi A, Yaghmaei M. Association between interleukin 4 gene seventy – base – pair variable number tandem repeats polymorphism and uterine leiomyoma. Gene Cell Tissue. 2014;1(2):19462. doi:10.17795/gct-19462
   Google Scholar
• Preacher KJ [Internet] Calculation for the chi-square test: an interactive calculation tool for chi-square tests of goodness of fit and independence. 2001 [Computer software] Available from: http://quantpsy.org. Accessed 809, 2019.
   Google Scholar
• Waller M, Moss S, Watson J, Møller H. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomarkers Prev. 2017;16:2257–2261. doi:10.1158/1055-9965.EPI-07-0262
   Web of Science ®Google Scholar
• Ponder BA. Genetic predisposition to cancer. Br J Cancer. 1991;64(2):203–204. doi:10.1038/bjc.1991.2751892744
   PubMed Web of Science ®Google Scholar
• Liotta L, Petricoin E. Molecular profiling of human cancers. Nature Rev Genet. 2000;1:48–56. doi:10.1038/3504956711262874
   PubMed Web of Science ®Google Scholar
• Apostolou P, Fostira F. Hereditary breast cancer: the era of new susceptibility genes. Biomed Res Int. 2013;2013:747318. doi:10.1155/2013/74731823586058
   PubMed Web of Science ®Google Scholar
• Duan Y, Pan C, Shi J, Chen H, Zhang S. Association between interleukin-4 gene intron 3 VNTR polymorphism and cancer risk. Cancer Cell Int. 2014;14(1):131. doi:10.1186/1475-2867-14-6725484626
   PubMed Web of Science ®Google Scholar
• Atoum MF, Tanashat RQ, Mahmoud SA. Negative association of the HLA-DQB1*02 allele with breast cancer development among Jordanians. Asian Pac J Cancer Prev. 2014;15(17):7337–7341. doi:10.7314/APJCP.2014.15.17.733725227839
   PubMedGoogle Scholar
• Atoum MF, Alzoughool F. Reduction in breast cancer susceptibility due to XbaI gene polymorphism of alpha estrogen receptor gene in Jordanians. Breast Cancer (Dove Med Press). 2017;9:45–49. doi:10.2147/BCTT.S12565228182136
   PubMed Web of Science ®Google Scholar
• Abdel-Razeq H, Al-Omari A, Zahran F, Arun B. Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan. BMC Cancer. 2018;18(1):152. doi:10.1186/s12885-018-4242-829409476
   PubMed Web of Science ®Google Scholar
• AL-Eitan L, Jamous R, Khasawneh R. Candidate gene analysis of breast cancer in the Jordanian population of Arab descent: a case-control study. Cancer Invest. 2017. doi:10.1080/07357907.2017.1289217
   PubMed Web of Science ®Google Scholar
• Al-Zoubi MS, Mazzanti CM, Zavaglia K, et al. Homozygous T172T and heterozygous G135C variants of homologous recombination repairing protein RAD51 are related to sporadic breast cancer susceptibility. Biochem Genet. 2016;54(1):83–94. doi:10.1007/s10528-015-9703-z26650628
   PubMed Web of Science ®Google Scholar
• Todaro M, Lombardo Y, Francipane MG, et al. Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4. Cell Death Differ. 2008;15:762–772. doi:10.1038/sj.cdd.440230518202702
   PubMed Web of Science ®Google Scholar
• Wu MC 1, Huang CM, Tsai JJ, Chen HY, Tsai FJ. Polymorphisms of the interleukin-4 gene in chinese patients with systemic lupus erythematosus in Taiwan. Lupus. 2003;12(1):21–25. doi:10.1191/0961203303lu249oa12587822
   PubMed Web of Science ®Google Scholar
• Mittal RD, Manchanda PK. Association of interleukin (IL)-4 intron-3 and IL-6-174 G/C gene polymorphism with susceptibility to end-stage renal disease. immunogenetics. 2007;59(2):159–165. doi:10.1007/s00251-006-0182-617203290
   PubMed Web of Science ®Google Scholar
• Tsai FJ, Chang CH, Chen CC, Hsia TC, Chen HY, Chen WC. Interleukin-4 gene intron-3 polymorphism is associated with transitional cell carcinoma of the urinary bladder. BJU Int. 2005;95(3):432–435. doi:10.1111/j.1464-410X.2005.05315.x15679809
   PubMed Web of Science ®Google Scholar
• Tsai MH, Chen WC, Tsai CH, Hang LW, Tsai FJ. Interleukin-4 gene, but not the interleukin-1 beta gene polymorphism, is associated with oral cancer. J Clin Lab Anal. 2005;19(3):93–98. doi:10.1002/jcla.2008715900573
   PubMed Web of Science ®Google Scholar
• Shekari M, Kordi-Tamandani DM, MalekZadeh K, Sobti RC, Karimi S, Suri V. Effect of anti-inflammatory (IL-4, IL-10) cytokine genes in relation to risk of cervical carcinoma. Am J Clin Oncol. 2012;35(6):514–519. doi:10.1097/COC.0b013e31822d9c1222157213
   PubMed Web of Science ®Google Scholar
• Ibrahimi M, Jamalzei B, Akbari ME, et al. Association between interleukin 4 (IL-4) VNTR, gene polymorphism, and breast cancer susceptibility in Iranian population: experimental and web base analysis. Bratisl Lek Listy. 2018;119(10):651–654. doi:10.4149/BLL_2018_11630345774
   PubMed Web of Science ®Google Scholar
• Jia Y, Xie X, Shi X, Li S. Associations of common IL-4 gene polymorphisms with cancer risk: a meta-analysis. Mol Med Rep. 2017;16(2):1927–1945. doi:10.3892/mmr.2017.682228656227
   PubMed Web of Science ®Google Scholar
• Hedderson MM, Malone KE, Daling JR, White E. Allergy and risk of breast cancer among young women (United States). Cancer Causes Control. 2003;14(7):619–626.14575359
   PubMed Web of Science ®Google Scholar
• Lange CA, Yee D. Progesterone and breast cancer.Womens. Health (Lond Engl). 2008;4(2):151–162. doi:10.2217/17455057.4.2.151
   Google Scholar